Listed below are the current guidelines and updates in development. Topics are prioritized for development by the Clinical Guidelines Committee. During the development process, guidelines are made available for open comment to identify any errors or gaps in the draft guideline prior to publication to ensure greater transparency. Check back here for opportunities to submit topics for consideration and to review guidelines open for comment when available. To learn more about the Endocrine Society guideline development process, access the guideline development methodology page.
Anticipated Publication: June 2024
This is an update to the 2011 guideline.
Anticipated Publication: Spring 2025
This is an update of the 2013 guideline in collaboration with the European Society of Endocrinology.
Anticipated Publication: Spring 2025
This is an update to the 2016 guideline.
Anticipated: Summer 2026
In empanelment
Pheochromocytoma and Paraganglioma (Expert Consensus Report)
In queue for development
This is an update to the 2014 guideline
Endocrine Society guidelines can be retired for any of the following reasons: the guideline as a whole is sufficiently out of date that it is no longer relevant to clinical practice; one or more of the guideline recommendations contain important inaccuracies or omissions that, if followed precisely, could lead to substandard patient care or potential harm; or the guideline has been replaced by a more recent publication.
Access guideline recommendations, patient information, and clinical education modules for a range of endocrine topics plus dozens of interactive decision algorithms and other point-of-care tools.